Skip to content

Change of Range of Motion of TMJ After Correction of Pelvic a Symmetry in Women With Cyclic Pelvic Pain

Change of Range of Motion of TMJ After Correction of Pelvic a Symmetry in Women With Cyclic Pelvic Pain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04077788
Enrollment
30
Registered
2019-09-04
Start date
2019-11-08
Completion date
2020-08-11
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Pain

Brief summary

Clinical experiences have shown that significant pain regression during a menstrual cycle has been often achieved by the use of spinal manipulative therapy (SMT) indicated in women with primary dysmenorrhea with coexisting functional disorders of lumbosacral (LS) spine. Namely, by activation of the nociceptive and vegetative system, LS spine disorders, before all segmental dysfunction and degenerative changes, can induce referred pain and reflex disturbances of pelvic organs (somatovisceral reflexes). Since significant improvement or disappearance of pain during a menstrual cycle is often achieved with adequate therapy of coexisting vertebral disorders in women with primary dysmenorrhea, it is important to recognise latent or manifest vertebral disorders in dysmenorrheic women using clinical examination (Grgić, 2009).

Interventions

OTHERmuscle energy technique

Muscle energy technique: 1. Application of MET for bone of pelvis: I) Pubis: 1. Cranial Os pubis. 2. Caudal os pubis. II) ileum: 1. Anterior ileum. 2. Posterior ileum. 3. External Rotation (In flare) Lesion. 4. Internal Rotation (Out flare) Lesion. III) sacrum: 1. Forward torsion of sacrum. 2. Backward torsion of sacrum. 2. Muscle energy technique for specific muscles of pelvis and spine: 1. Stretch of the Psoas Major. 2. Stretch of the paravertebral muscle. 3. Stretch of the piriforms.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* The age of the participants will be ranged from 25 to 35 years. * Their body mass index will be ranged from 20 to 25 kg/m2. * They will have regular menstrual cycle. * They will not receive any hormonal therapy or taking any regular drugs.

Exclusion criteria

The potential participants will be excluded if they meet one of the following criteria: * Pelvic inflammatory diseases. * Any pelvic pathological condition

Design outcomes

Primary

MeasureTime frameDescription
Weight-Height Scale3 monthsIt will be used for measuring the body weight and height of each patient participating in the study to calculate the patient's body mass index (BMI). Body mass index (BMI) = Weight (Kg
Visual analogue scale (VAS)3 monthsain will be assessed by visual analogue scale. It is 10 cm horizontal line with one end described as (no pain=0) and other end (worst pain=10). It was considered a valid way for assessing pain. It allowed graphic representation and numerical analysis of collected data (Boonstra et al., 2008) (Appendix III).
Menstrual Distress Questionnaire (MDQ)3 monthsThe MDQ is a 46-item self-report inventory for use in the assessment and treatment of premenstrual and menstrual symptoms. The MDQ can distinguish cyclical from noncyclical changes in physical symptoms, mood and behavior, and arousal.
jaw movement3 monthsMaximal vertical mouth opening (MIO): From sitting position, with the use of the calliper, the distance between the incisal edges along the midline of the upper and lower central incisors without pain was measured, by placing one end of the poley gauge against the incisal edge of one of the upper central incisors, and the other end against the incisal edge of the opposing lower incisor. The distance recorded in millimeters, the subjects was instructed to open your mouth as wide as possible without causing pain or discomfort. The poley gauge was sterilized with antiseptic solution before and after each measur

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026